ContractLicense Agreement • March 31st, 2003 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances)
[Portions of this Exhibit have been omitted pursuant to a request for confidentiality under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A copy of this Exhibit with all sections intact has been filed separately with the Securities and Exchange Commission.]
